Analyzing PACS Group (PACS) and The Competition

PACS Group (NYSE:PACS) is one of 93 publicly-traded companies in the “Medical Services” industry, but how does it compare to its competitors? We will compare PACS Group to similar companies based on the strength of its dividends, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

Profitability

This table compares PACS Group and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PACS Group	N/A	N/A	N/A
PACS Group Competitors	-785.52%	-52.88%	-11.59%

Risk and Volatility

PACS Group has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, PACS Group’s competitors have a beta of 1.53, indicating that their average stock price is 53% more volatile than the S&P 500.

Valuation & Earnings

This table compares PACS Group and its competitors gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
PACS Group	$3.11 billion	$112.87 million	39.78
PACS Group Competitors	$9.91 billion	$239.88 million	13.54

PACS Group’s competitors have higher revenue and earnings than PACS Group. PACS Group is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a summary of current ratings and recommmendations for PACS Group and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	1	1	3	0	2.40
PACS Group Competitors	607	2464	5091	184	2.58

PACS Group presently has a consensus target price of $26.25, suggesting a potential upside of 112.84%. As a group, “Medical Services” companies have a potential upside of 368.29%. Given PACS Group’s competitors stronger consensus rating and higher possible upside, analysts clearly believe PACS Group has less favorable growth aspects than its competitors.

Insider and Institutional Ownership

58.1% of shares of all “Medical Services” companies are owned by institutional investors. 13.2% of shares of all “Medical Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

PACS Group competitors beat PACS Group on 9 of the 13 factors compared.

PACS Group Company Profile

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.